Salicylic Acid

Salicylic Acid

SCHEMBL15623328

CCCC.O=C(O)O.O=C(O)c1ccccc1O

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHE

The experimentally established mechanism targets of Salicylic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.75
KDM4E B2RXH2 6/20 0.75
HPGD P15428 6/20 0.75
SMN1; SMN2 Q16637 2/20 0.75
CA12 O43570 1/20 0.75
CA1 P00915 1/20 0.75
CA2 P00918 1/20 0.75
HMGB1 P09429 1/20 0.75
CA4 P22748 1/20 0.75
CA6 P23280 1/20 0.75
CA7 P43166 1/20 0.75
CA9 Q16790 1/20 0.75
NAPRT Q6XQN6 1/20 0.75
CA14 Q9ULX7 1/20 0.75
ALOX15 P16050 2/20 0.52
HSD17B10 Q99714 4/20 0.50
LMNA P02545 3/20 0.49
NAAA Q02083 1/20 0.49
ALOX12 P18054 1/20 0.49
TSHR P16473 5/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Salicylic Acid SCHEMBL1003308 0.98 ALDH1A1 (0.78) ALDH1A1KDM4EHPGDSMN1; SMN2CA12
Salicylic Acid SCHEMBL4907211 0.96 ALDH1A1 (0.75) ALDH1A1KDM4EHPGDSMN1; SMN2CA12
Salicylic Acid SCHEMBL1829341 0.91 ALDH1A1 (0.82) ALDH1A1KDM4EHPGDSMN1; SMN2CA12
Salicylic Acid SCHEMBL8621859 0.90 ALDH1A1 (0.72) ALDH1A1KDM4EHPGDSMN1; SMN2CA12
Salicylic Acid SCHEMBL294304 0.90 ALDH1A1 (0.72) ALDH1A1KDM4EHPGDSMN1; SMN2CA12
Salicylic Acid SCHEMBL25288775 0.89 ALDH1A1 (0.78) ALDH1A1KDM4EHPGDSMN1; SMN2CA12
Salicylic Acid SCHEMBL31332109 0.89 ALDH1A1 (0.78) ALDH1A1KDM4EHPGDSMN1; SMN2CA12
Salicylic Acid SCHEMBL28438953 0.89 ALDH1A1 (0.95) ALDH1A1KDM4EHPGDSMN1; SMN2CA12
Salicylic Acid SCHEMBL5183939 0.89 ALDH1A1 (0.95) ALDH1A1KDM4EHPGDSMN1; SMN2CA12
Salicylic Acid SCHEMBL27817575 0.89 ALDH1A1 (0.95) ALDH1A1KDM4EHPGDSMN1; SMN2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3383835-A1 A METHOD FOR RECOVERING AN AROMATIC ALCOHOL FROM A MELT POLYMERIZATION, AND A SYSTEM FOR RECOVERING THE SAME SABIC Global Technologies B.V. (NL) 2018-10-10 EP disclosed
US-9765012-B2 Method for producing diaryl carbonate COVESTRO DEUTSCHLAND AG (DE) 2017-09-19 US disclosed
EP-3215551-A1 METHOD FOR MAKING POLYCARBONATE USING A LIQUID KETONE MIXTURE SABIC Global Technologies B.V. (NL) 2017-09-13 EP disclosed
WO-2017093974-A1 A METHOD FOR RECOVERING AN AROMATIC ALCOHOL FROM A MELT POLYMERIZATION, AND A SYSTEM FOR RECOVERING THE SAME SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2017-06-08 WO disclosed
WO-2016071815-A1 METHOD FOR MAKING POLYCARBONATE USING A LIQUID KETONE MIXTURE SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2016-05-12 WO disclosed
EP-2970096-A2 PROCESS FOR PURIFICATION OF DIPHENYL CARBONATE FOR THE MANUFACTURING OF HIGH QUALITY POLYCARBONATE SABIC Global Technologies B.V. (NL) 2016-01-20 EP disclosed
US-20160002143-A1 METHOD FOR PRODUCING DIARYL CARBONATE BAYER MATERIALSCIENCE AG (DE) 2016-01-07 US disclosed
WO-2014141107-A2 PROCESS FOR PURIFICATION OF DIPHENYL CARBONATE FOR THE MANUFACTURING OF HIGH QUALITY POLYCARBONATE SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2014-09-18 WO disclosed
WO-2014141108-A1 PRODUCTION OF A POLYCARBONATE WITH LIMITED METAL RESIDUALS SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2014-09-18 WO disclosed
WO-2014045086-A1 PROCESS FOR THE CONTINUOUS MANUFACTURE OF ARYL ALKYL CARBONATE AND/OR DIARYL CARBONATE USING VAPOR RECOMPRESSION SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2014-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160002143-A1 METHOD FOR PRODUCING DIARYL CARBONATE PGLS, ALPG, DPAGT1 ALDH1A1 4011/4885KDM4E 2057/4885HPGD 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.